Korean J Physiol Pharmacol.
1997 Aug;1(4):445-456.
Effects of ginsenosides on the mechanism of histamine release in the
guinea pig lung mast cells activated by specific antigen-antibody
reactions
- Affiliations
-
- 1Department of Pharmacology, Yonsei University, College of Medicine,
CPO Box 8044, Seoul 120-752, South Korea.
Abstract
-
We previously reported that some components of ginsenosides decreased
mediator releases evoked by the activation of mast cells with specific
antigen-antibody reactions. This study aimed to assess the effects of
ginsenosides (Rb2, Re) on the mechanism of histamine release in the
mast cell activation. We partially purified guinea pig lung mast cells
by using enzyme digestion, the rough and the discontinuous percoll
density gradient method. Mast cells were sensitized with IgG1 and
challenged with ovalbumin (OA). Histamine was assayed by fluorometric
analyzer, leukotrienes by radioimmunoassay. Phospholipase D (PLD)
activity was assessed more directly by the production of
(3H)phosphatidylbutanol (PBut) which was produced by PLD-mediated
transphosphatidylation in the presence of butanol. The amount of
1,2-diacylglycerol (DAG) were measured by the (3H)DAG labeled with
(3H)palmitic acid or (3H)myristic acid. Pretreatment of Rb2 (300 microgram)
significantly decreased histamine release by 60%, but Re (300 gg)
increased histamine release by 34%. Leukotrienes release in Rb2 was
decreased by 40%, Re was not affected in the leukotrienes release
during mast cell activations. An increasing PLD activity during mast
cell activation was decreased by the dose-dependent manner in the
pretreatment of Rb2, but Re pretreatment facilitated the increased PLD
activity during mast cell activation. The amount of DAG produced by
phospholipase C (PLC) activity was decreased by Rb2 pretreatment, but
Re pretreatment was not affected. The amount of mass DAG was decreased
by Rb2 and Re pretreatment during mast cell activation. The data
suggest that Rb2 purified from Korean Red Ginseng Radix inhibits the
DAG which is produced by the activation of mast cells with
antigen-antibody reactions via both phosphatidylinositide-PLC and
phosphatidylcholine-PLD systems, and then followed by the inhibition of
histamine release. However, Re increases histamine release by
stimulation of DAG production, which is mediated by
phosphatidylcholine-PLD system rather than by phosphatidylinositide-PLC
system, but inhibits the mass DAG production. Thus, it could be
inferred that other mechanisms play a role in the increase of histamine
release during mast cell activation.